Authors


Glenn Tillotson, PhD

Latest:

Pan-resistant, Currently Untreatable Gram-Negative Infections Come Closer to Home

The global emergence of antimicrobial resistance among gram-negative species is a major public health concern.


Ravina Kullar, PharmD, MPH, FIDSA*

Latest:

Investigational Treatments for Clostridioides difficile Infection

The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.


Jonna Lorenz

Latest:

Pandemic Disrupts Progress Toward Hepatitis B Control

Efforts to ramp up hepatitis B vaccination at birth and in infancy are crucial to controlling the disease in Africa, which accounted for 66% of new infections in 2019.


Joseph DeSimone Jr, MD

Latest:

What's in the Pipeline?

A look at up-and-coming HIV drugs in development.


Jessica Robinson, PharmD, BCPS

Latest:

A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.



Caitlyn Fitzpatrick

Latest:

HCV Testing Remains Low Among High-Risk Population

When the US Preventive Services Task Force (USPSTF) recommended that all baby boomers undergo a one-time hepatitis C screening in 2013, testing prevalence increased. However, the rate is still lower than officials would like to see.


JOSE MAURO PERALTA, MD, PHD

Latest:

Is Investment in New Technologies for Diagnosing Schistosomiasis Justified in an Era of Schistosoma Elimination?

The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.


Meghan Jeffres, PharmD, BCIDP*

Latest:

Two Allergies or Cross-Reactive?

The story of penicillin and cefazolin.


William Perlman, PhD, CMPP

Latest:

CabA May Hold Key to Reducing Food-borne Illnesses Caused by Vibrio vulnificus

By targeting CabA, an extracellular matrix protein essential for biofilm formation, it may be possible to reduce the incidence of food-borne illnesses caused by the potentially lethal Vibrio vulnificus marine bacterium found in biofilms on oyster shells and meat.


Ariane van der Straten, PhD, MPH

Latest:

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.


Mike Hennessy, Sr, Chairman

Latest:

Reassessing Practices Is Critical During an Infectious Disease Outbreak

The constant reassessment of business practices is necessary to ensure that practitioners are not wasting valuable time, resources, and effort on activities that are not producing the desired results.


Jonathan Lapin, PharmD

Latest:

Role of Immunosuppression on Community-Acquired Clostridioides difficile Risk

CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.


MONIQUE R. BIDELL, PHARMD, BCPS

Latest:

The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions

Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.


P. BRANDON BOOKSTAVER, PHARMD*

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


JOHN CHAN, MD

Latest:

The Case of Late Aspergillus Fumigatus Infection of Implantable Cardioverter Defibrillator Leads

Quick action was needed against this very rare cause of fungal endocarditis.


Jason J. Schafer, PharmD, MPH, BCPS AQ-ID, AAHIVP

Latest:

The Power of PrEP

The results of a new study demonstrate that PrEP can reduce new infections within a population even when the risk of HIV remains high and other proven treatment and prevention strategies are optimized.


Bruce M. Jones, PharmD, BCPS

Latest:

Starting an Inpatient Penicillin Skin Testing Service in 2023

Patients with a penicillin allergy can be safely delabeled using minimal resources, opening up treatment options.


Shawn MacVane, PharmD

Latest:

Fluoroquinolone Antibiotics: More Recommendations for Prudent Use

Despite concerning findings and warnings, fluoroquinolones have remained one of the world’s most commonly prescribed antibiotic classes, with the United States accounting for more than 32 million prescriptions in 2015 alone.


Leah M. Johnson, PhD

Latest:

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.


Maricelle O. Monteagudo-Chu, PharmD, BCPS AQ-ID

Latest:

Early Antibiotic Therapy Does Not Improve Mortality in Patients with CAUTI

Catheter-associated urinary tract infections (CAUTIs) account for about 40% of all nosocomial infections in hospitals and nursing homes.


Jane Abernathy, MD Candidate

Latest:

An Unusual Case of Testicular Swelling in a Patient With HIV

Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.


Gabriel Sandkovsky, MD

Latest:

Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal Cohabitation

A patient presented with a history of uncontrolled HIV and a history of polysubstance use.


Lauren A. Igneri, PharmD, BCPS, BCCCP

Latest:

More Than Surviving Sepsis: Everything Old Is New Again

Investigators are dusting off angiotensin II and ascorbic acid for renewed use in treating sepis and septic shock.


JOHN MOHR, PHARMD

Latest:

Implications of the 21st Century Cures Act on Antibiotic Drug Development

Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.


ANDREW LEE, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


KRISTINE LA, PHARMD CANDIDATE 2018

Latest:

Exciting New Hepatitis C Therapies Approved at the End of 2017

Treatment-experienced patients still have some good options.



MONICA V. MAHONEY, PHARMD, BCPS AQ-ID, BCIDP*

Latest:

Regdanvimab—A New Attack of the (Mono)Clones

A review of the neutralizing antibody that was studied in a phase 2/3 trial in outpatients with mild to moderate infections of COVID-19.


© 2024 MJH Life Sciences

All rights reserved.